cancer – Medxy AI

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

By MedXY 09/14/2025

New research reveals that a protein called plasmin weakens human immune response against cancer compared to chimpanzees, offering promising strategies to enhance cancer immunotherapy.

Clinical Updates Wellness & Lifestyle

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

By MedXY 09/08/2025

Venous and arterial thrombotic events in cancer patients are underreported in clinical trials, impairing risk assessment and prevention strategies. Uniform and comprehensive reporting is imperative to improve patient outcomes and guide therapeutic decisions.

Medical News Wellness & Lifestyle

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters

By MedXY 08/26/2025

Emerging research reveals that any alcohol consumption increases the risk of dozens of diseases, debunking myths about moderate drinking's benefits—especially for Chinese men. Quitting alcohol triggers remarkable health improvements and reduces mortality risk.

Clinical Updates Wellness & Lifestyle

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？

By MedXY 08/26/2025

An 18-month course of rivaroxaban significantly lowers recurrent venous thromboembolism compared to 6 months in cancer patients with low-risk pulmonary embolism without a substantial increase in major bleeding risk.

Clinical Updates Wellness & Lifestyle

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications

By MedXY 08/21/2025

Low-dose aspirin added to anticoagulation for cancer-associated VTE reduces recurrence and PE-related mortality but increases bleeding risk, without improving overall survival or net clinical benefit over 6 months.

Clinical Updates Wellness & Lifestyle

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential

By MedXY 08/21/2025

Circular RNAs (circRNAs) are pivotal regulators in cancer biology and immunotherapy, acting through mechanisms such as miRNA sponging, protein interactions, and translation. Their modulation of tumor immune microenvironment offers promising therapeutic avenues despite current technical challenges.

Clinical Updates Wellness & Lifestyle

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication

By MedXY 08/06/2025

A novel bacteria-based therapy using two natural strains demonstrates complete tumor clearance in immunocompromised models, offering hope for cancer patients unsuitable for current immunotherapies.

Medical News Wellness & Lifestyle

Pickled Delights: Delicious but Potentially Dangerous?

By MedXY 08/06/2025

Explore the beloved tradition of pickled foods, their health impacts, and safer consumption tips.

Clinical Updates Wellness & Lifestyle

Overcoming PD-1 Inhibitor Resistance: Six Emerging Strategies from the 2025 ASCO Annual Meeting

By MedXY 08/06/2025

PD-1 inhibitor resistance is a major hurdle in cancer immunotherapy. Six leading combination strategies—including chemotherapy, anti-angiogenic agents, radiotherapy, novel checkpoint inhibitors, microbiome modulation, and ADCs—offer new hope for overcoming resistance and improving patient outcomes.

Clinical Updates Wellness & Lifestyle

Elevated D-Dimer Levels: Beyond Pulmonary Embolism—Uncommon Conditions Many Doctors Overlook

By MedXY 08/03/2025

D-dimer is a specific fibrin degradation product indicative of blood clot formation and breakdown. Elevated levels signal various conditions beyond pulmonary embolism, including cardiovascular diseases, malignancies, and infections.

Wellness & Lifestyle

Unveiling the Hidden Dangers: How Dining Habits Can Impact Your Health

By MedXY 07/26/2025

Explore how everyday dining habits can lead to health risks, including cancer, and learn preventive measures.